{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53583"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53583","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Examining the predictive role of neurocognitive functioning in exposure therapy response","abstract":"Anxiety and fear-based disorders have an estimated lifetime prevalence of 31.6% in adults and are associated with significant individual and societal burden. Exposure-based cognitive behavioral therapy (CBT) is well-established as a first-line treatment for these disorders, but non-response rates nonetheless remain high. Neurocognitive functioning represents a theoretically relevant but relatively understudied potential predictor of CBT response. Anxiety disorders are associated with moderate impairment in a range of neurocognitive domains, including executive functioning, working memory, processing speed, and episodic memory. Multiple mechanisms of exposure therapy, including extinction learning, are hypothesized to rely on cognitive abilities. Fifty adults diagnosed with social anxiety disorder, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, or post-traumatic stress disorder were recruited from a 12-week trial of exposure-based CBT. Participants completed a neuropsychological battery designed to assess domains of cognitive impairment observed across anxiety-related disorders and theoretically relevant to CBT success, including working memory, sustained attention, processing speed, verbal memory, visual memory, verbal fluency, inhibitory control, and set-shifting. Treatment outcome was assessed weekly with the Overall Anxiety Severity and Impairment Scale. I hypothesized that poorer cognitive functioning would be associated with greater anxiety at baseline and would predict poorer treatment response. Preliminary analyses indicated that only visuospatial working memory and immediate verbal recall were significantly associated with baseline anxiety. Furthermore, the sample showed relatively strong cognitive functioning with scores that were generally in range for what would be expected in healthy samples. Multilevel models were used to examine relationships between each cognitive predictor and treatment response. Subsequently, stepwise linear regression was used to examine the potential significance of unique combinations of predictors on treatment response. Contrary to hypotheses, no cognitive variable significantly predicted the rate of symptom change over the course of treatment. Effect sizes were small across all models. Overall, findings did not support the hypothesis that neurocognitive functioning is a significant predictor of CBT response across anxiety and fear-based disorders. A potential limitation to this conclusion is that these findings were derived from a relatively high functioning sample, leaving open the possibility that neurocognitive prediction of treatment outcome is specific to the most impaired subsamples.","abstract_html":"Anxiety and fear-based disorders have an estimated lifetime prevalence of 31.6% in adults and are associated with significant individual and societal burden. Exposure-based cognitive behavioral therapy (CBT) is well-established as a first-line treatment for these disorders, but non-response rates nonetheless remain high. Neurocognitive functioning represents a theoretically relevant but relatively understudied potential predictor of CBT response. Anxiety disorders are associated with moderate impairment in a range of neurocognitive domains, including executive functioning, working memory, processing speed, and episodic memory. Multiple mechanisms of exposure therapy, including extinction learning, are hypothesized to rely on cognitive abilities. Fifty adults diagnosed with social anxiety disorder, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, or post-traumatic stress disorder were recruited from a 12-week trial of exposure-based CBT. Participants completed a neuropsychological battery designed to assess domains of cognitive impairment observed across anxiety-related disorders and theoretically relevant to CBT success, including working memory, sustained attention, processing speed, verbal memory, visual memory, verbal fluency, inhibitory control, and set-shifting. Treatment outcome was assessed weekly with the Overall Anxiety Severity and Impairment Scale. I hypothesized that poorer cognitive functioning would be associated with greater anxiety at baseline and would predict poorer treatment response. Preliminary analyses indicated that only visuospatial working memory and immediate verbal recall were significantly associated with baseline anxiety. Furthermore, the sample showed relatively strong cognitive functioning with scores that were generally in range for what would be expected in healthy samples. Multilevel models were used to examine relationships between each cognitive predictor and treatment response. Subsequently, stepwise linear regression was used to examine the potential significance of unique combinations of predictors on treatment response. Contrary to hypotheses, no cognitive variable significantly predicted the rate of symptom change over the course of treatment. Effect sizes were small across all models. Overall, findings did not support the hypothesis that neurocognitive functioning is a significant predictor of CBT response across anxiety and fear-based disorders. A potential limitation to this conclusion is that these findings were derived from a relatively high functioning sample, leaving open the possibility that neurocognitive prediction of treatment outcome is specific to the most impaired subsamples.","abstract_has_math":false,"creators":["Lubin, Rebecca Elizabeth"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Psychological & Brain Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Otto, Michael W."],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T20:42:13Z","subjects":["Clinical psychology"],"languages":["en_US"],"rights":["Attribution-NonCommercial 4.0 International"],"rights_urls":["http://creativecommons.org/licenses/by-nc/4.0/"],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0002-1960-8986"],"render_values":[{"text":"0000-0002-1960-8986","href":"https://orcid.org/0000-0002-1960-8986","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/53583","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53583","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53583","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Otto, Michael W."]},{"key":"dc:creator","label":"Author","values":["Lubin, Rebecca Elizabeth"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0002-1960-8986"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-02T14:21:47Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-10-02T14:21:47Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-10-01T22:15:20Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Psychological & Brain Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Clinical psychology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53583"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2026"]},{"key":"dc:description.abstract","label":"Abstract","values":["Anxiety and fear-based disorders have an estimated lifetime prevalence of 31.6% in adults and are associated with significant individual and societal burden. Exposure-based cognitive behavioral therapy (CBT) is well-established as a first-line treatment for these disorders, but non-response rates nonetheless remain high. Neurocognitive functioning represents a theoretically relevant but relatively understudied potential predictor of CBT response. Anxiety disorders are associated with moderate impairment in a range of neurocognitive domains, including executive functioning, working memory, processing speed, and episodic memory. Multiple mechanisms of exposure therapy, including extinction learning, are hypothesized to rely on cognitive abilities. Fifty adults diagnosed with social anxiety disorder, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, or post-traumatic stress disorder were recruited from a 12-week trial of exposure-based CBT. Participants completed a neuropsychological battery designed to assess domains of cognitive impairment observed across anxiety-related disorders and theoretically relevant to CBT success, including working memory, sustained attention, processing speed, verbal memory, visual memory, verbal fluency, inhibitory control, and set-shifting. Treatment outcome was assessed weekly with the Overall Anxiety Severity and Impairment Scale. I hypothesized that poorer cognitive functioning would be associated with greater anxiety at baseline and would predict poorer treatment response. Preliminary analyses indicated that only visuospatial working memory and immediate verbal recall were significantly associated with baseline anxiety. Furthermore, the sample showed relatively strong cognitive functioning with scores that were generally in range for what would be expected in healthy samples. Multilevel models were used to examine relationships between each cognitive predictor and treatment response. Subsequently, stepwise linear regression was used to examine the potential significance of unique combinations of predictors on treatment response. Contrary to hypotheses, no cognitive variable significantly predicted the rate of symptom change over the course of treatment. Effect sizes were small across all models. Overall, findings did not support the hypothesis that neurocognitive functioning is a significant predictor of CBT response across anxiety and fear-based disorders. A potential limitation to this conclusion is that these findings were derived from a relatively high functioning sample, leaving open the possibility that neurocognitive prediction of treatment outcome is specific to the most impaired subsamples."]},{"key":"dc:title","label":"Title","values":["Examining the predictive role of neurocognitive functioning in exposure therapy response"]}]}],"canonical_facts":{"dc:contributor.advisor":["Otto, Michael W."],"dc:creator":["Lubin, Rebecca Elizabeth"],"dc:date.accessioned":["2026-10-02T14:21:47Z"],"dc:date.available":["2026-10-02T14:21:47Z"],"dc:date.issued":["2026"],"dc:date.updated":["2026-10-01T22:15:20Z"],"dc:description":["2026"],"dc:description.abstract":["Anxiety and fear-based disorders have an estimated lifetime prevalence of 31.6% in adults and are associated with significant individual and societal burden. Exposure-based cognitive behavioral therapy (CBT) is well-established as a first-line treatment for these disorders, but non-response rates nonetheless remain high. Neurocognitive functioning represents a theoretically relevant but relatively understudied potential predictor of CBT response. Anxiety disorders are associated with moderate impairment in a range of neurocognitive domains, including executive functioning, working memory, processing speed, and episodic memory. Multiple mechanisms of exposure therapy, including extinction learning, are hypothesized to rely on cognitive abilities. Fifty adults diagnosed with social anxiety disorder, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, or post-traumatic stress disorder were recruited from a 12-week trial of exposure-based CBT. Participants completed a neuropsychological battery designed to assess domains of cognitive impairment observed across anxiety-related disorders and theoretically relevant to CBT success, including working memory, sustained attention, processing speed, verbal memory, visual memory, verbal fluency, inhibitory control, and set-shifting. Treatment outcome was assessed weekly with the Overall Anxiety Severity and Impairment Scale. I hypothesized that poorer cognitive functioning would be associated with greater anxiety at baseline and would predict poorer treatment response. Preliminary analyses indicated that only visuospatial working memory and immediate verbal recall were significantly associated with baseline anxiety. Furthermore, the sample showed relatively strong cognitive functioning with scores that were generally in range for what would be expected in healthy samples. Multilevel models were used to examine relationships between each cognitive predictor and treatment response. Subsequently, stepwise linear regression was used to examine the potential significance of unique combinations of predictors on treatment response. Contrary to hypotheses, no cognitive variable significantly predicted the rate of symptom change over the course of treatment. Effect sizes were small across all models. Overall, findings did not support the hypothesis that neurocognitive functioning is a significant predictor of CBT response across anxiety and fear-based disorders. A potential limitation to this conclusion is that these findings were derived from a relatively high functioning sample, leaving open the possibility that neurocognitive prediction of treatment outcome is specific to the most impaired subsamples."],"dc:identifier.orcid":["0000-0002-1960-8986"],"dc:identifier.uri":["https://hdl.handle.net/2144/53583"],"dc:language.iso":["en_US"],"dc:rights":["Attribution-NonCommercial 4.0 International"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc/4.0/"],"dc:subject":["Clinical psychology"],"dc:title":["Examining the predictive role of neurocognitive functioning in exposure therapy response"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Psychological & Brain Sciences"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:42:13Z"}